Development of effective heparin extraction method from pig by-products and analysis of their bioavailability

키워드

참고문헌 (33)

1. Choi JP, "Animal byproduct(blood)current status & usage", Korean J Food Sci Anim Resour, 2, pp.2~7 (2013)
2. Jeon KH, "Current production and utilization of animal by-products", Korean J Food Sci Anim Resour, 2, pp.8~16 (2013)
3. 윤성열, "Development of Commercially Viable Method of Conjugated Linoleic Acid Synthesis Using Linoleic Acid Fraction Obtained from Pork By-products", 한국축산식품학회지, 38(4), pp.693~702 (2018), 한국축산식품학회
4. Seung Yun Lee, "Development of batch processing to obtain bioactive materials from pork byproducts", Animal Production Science, 60(2), pp.316~ (2020), CSIRO Publishing[DOI]
5. Tyagi Amrish Kumar, "Conjugated linoleic acid producing potential of lactobacilli isolated from goat (AXB) rumen fluid samples", Animal Bioscience, 33(8), pp.1233~1241 (2020), 아세아·태평양축산학회[DOI]
6. Lee MS, "Heparin : physiology, pharmacology, and clinical application", Rev Cardiovasc Med, 16, pp.189~199 (2015)[DOI]
7. W. H. Howell, "TWO NEW FACTORS IN BLOOD COAGULATION—HEPARIN AND PRO-ANTITHROMBIN", American Journal of Physiology-Legacy Content, 47(3), pp.328~341 (1918), American Physiological Society[DOI]
8. M Petitou, "1976–1983, a critical period in the history of heparin: the discovery of the antithrombin binding site", Biochimie, 85(1-2), pp.83~89 (2003), Elsevier BV[DOI]
9. Rebecca Lever, "Novel drug development opportunities for heparin", Nature Reviews Drug Discovery, 1(2), pp.140~148 (2002), Springer Science and Business Media LLC[DOI]
10. Sun W, "Spectrophotometric and voltammetric studies on the interaction of heparin with crystal violet and its analytical application", S Afr J Chem, 60, pp.42~46 (2007)
11. Abbott EC, "The influence of a heparin-like compound on hypertension, electrolytes and aldosterone in man", Can Med Assoc J, 94, pp.1155~1164 (1966)
12. JEAN E. SEALEY, "Inhibition of renin by heparin", The Journal of Clinical Endocrinology & Metabolism, 27(5), pp.699~705 (1967), The Endocrine Society[DOI]
13. Susie D, "Antihypertensive action of heparin : role of the renin‐angiotensin aldosterone system and prostaglandins", J Clin Pharmacol, 33, pp.342~347 (1993)
14. Droste JC, "Stability and in vitro efficacy of antibiotic–heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis", J Antimicrob Chemother, 51, pp.849~855 (2003)[DOI]
15. Marisa H. Miceli, "In vitro analyses of the effects of heparin and parabens on Candida albicans biofilms and planktonic cells", Antimicrobial Agents and Chemotherapy, 56(1), pp.148~153 (2011), American Society for Microbiology[DOI]
16. Philip M. Hanno, "Heparin as antibacterial agent in rabbit bladder", Urology, 12(4), pp.411~415 (1978), Elsevier BV[DOI]
17. Walter Rosett, "Antimicrobial Activity of Heparin", Journal of Clinical Microbiology, 11(1), pp.30~34 (1980), American Society for Microbiology[DOI]
18. Carla Renata Arciola, "Staphylococcus epidermidis–fibronectin binding and its inhibition by heparin", Biomaterials, 24(18), pp.3013~3019 (2003), Elsevier BV[DOI]
19. Charles AF, "Studies on heparin I. The preparation of heparin", Int J Biol Chem, 102, pp.425~429 (1933)
20. Charles AF, "Studies on heparin Ⅱ. Heparin in various tissues", Int J Biol Chem, 102, pp.431~435 (1933)
21. Charles AF, "Studies on heparin Ⅲ. The purification of heparin", Int J Biol Chem, 102, pp.437~448 (1933)
22. Leon Freeman, "Determination of tissue heparin", Archives of Biochemistry and Biophysics, 70(1), pp.169~177 (1957), Elsevier BV[DOI]
23. Nicola Volpi, "Disaccharide Analysis and Molecular Mass Determination to Microgram Level of Single Sulfated Glycosaminoglycan Species in Mixtures Following Agarose-Gel Electrophoresis", Analytical Biochemistry, 273(2), pp.229~239 (1999), Elsevier BV[DOI]
24. Sarwar MI, "Heparin can be isolated and purified from bovine intestine by different techniques", Int J Pharm Sci Invent, 2, pp.21~25 (2013)
25. Arumugam M, "Extraction of heparin and heparin-like substance from marine mesogastropod mollusc Turritella attenuata(Lamarck, 1779)", Indian J Exp Biol, 42, pp.529~532 (2004)
26. D.W. Cushman, "Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung", Biochemical Pharmacology, 20(7), pp.1637~1648 (1971), Elsevier BV[DOI]
27. Stephen R. Delaney, "Quantitation of the sulfated disaccharides of heparin by high performance liquid chromatography", Analytical Biochemistry, 106(1), pp.253~261 (1980), Elsevier BV[DOI]
28. Michael L. Trehy, "Analysis of heparin sodium by SAX", HPLC for contaminants and impurities, 2009, pp.49(3), 670~673[DOI]
29. Toshio Imanari, "High-performance liquid chromatographic analysis of g;ycosaminoglycan-derived oligosaccharides", Journal of Chromatography A, 720(1-2), pp.275~293 (1996), Elsevier BV[DOI]
30. Bo Yang, "Disaccharide analysis of glycosaminoglycan mixtures by ultra-high-performance liquid chromatography–mass spectrometry", Journal of Chromatography A, 1225, pp.91~98 (2012), Elsevier BV[DOI]
31. Christiane Auray-Blais, "Efficient analysis of urinary glycosaminoglycans by LC-MS", MS in mucopolysaccharidoses type I, II and VI, 2011, pp.102(1), 49~56[DOI]
32. Christiane Auray-Blais, "An improved method for glycosaminoglycan analysis by LC–MS", MS of urine samples collected on filter paper, 2012, pp.413(7-8), 771~778[DOI]
33. N D Rawlings, "Evolutionary families of peptidases", Biochemical Journal, 290(1), pp.205~218 (1993), Portland Press Ltd.[DOI]

관련 논문AI추천